NEMP1 is highly expressed in breast cancers and promotes tamoxifen resistance in breast cancer cells in vitro by regulating expression of nuclear receptor coactivator 1 (NCOA1/SRC1) (Liu et al., 2019). Here, SRC is linked to breast carcinoma.